Webinar - MLR of the future: Accomplish review, approval and delivery in <24 hours

Rapid innovation and higher rate of regulatory approvals, in the life sciences industry, have led to faster product launches and increase in product-related content volumes. Likewise, information consumption patterns of HCPs and patients have moved towards on-demand, personalized, and real-time digital content. Organizations are relying on digital channels to reach target audience– more than they ever did.

The result- content proliferation, thereby putting pressure on MLR review teams to deliver more content and at a much faster rate.

We believe that, in near future promotional content will need to be reviewed and published to market in less than 24 hours post authoring. Organizations that can truly deliver compliant content on-demand will undoubtedly have an advantage over competition.

16 MAR 2022
12:00 – 12:45 ET
Virtual
Watch Video

Thank you for your interest. We are no longer accepting registrations for this event.

What you will learn

Roadmap to prepare for the future of material reviews

Role of AI in driving productivity and cost efficiencies for material review

Best practices in leading organizations to achieve faster, high quality, and compliant content

Panelists

 
Erika Song
Erika Song
Director, Marketing Operations
Gilead Sciences
Georgios Tramountanis
Georgios Tramountanis
Head- Global Oncology Medical Information, Medical Review and Digital Strategy
Takeda Oncology
Georgia Gayle
Georgia Gayle
Head of Commercial Promotional Review and Marketing Operations (US/Global and Japan)
Alexion Pharmaceuticals
Luis Albuquerque
Luis Albuquerque
Associate Director Content Factory
Eli Lilly and Company
Jeremy Richter
Jeremy Richter
Senior Director, MLR and Content Strategy
Indegene